Selvita reports growing sales in Q2 and Q3, and projects increased profitability in H2 2024 PR Newswire KRAKÓW, Poland, Sept. 24, 2024 KRAKÓW, Poland , Sept. 24, 2024 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe , has published its financial results for Q2 2024, earnings estimates for Q3 204 and backlog for 2024 and 2025. Financial and Operational Highlights Selvita reports revenue growth in each subsequent quarter of 2024....